Atrás
Rango del Día
$203.86
$208.72
Rango de 52 Semanas
$120.72
$233.60
Volumen
1,958,769
Promedio 50D / 200D
$217.05
/
$182.52
Cierre Anterior
$206.40
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 31.2 | 0.3 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 0.7 | 3.8 |
| Rev Growth 5Y % | 8.2 | 10.0 |
| D/E | — | 0.2 |
Precio Objetivo de Analistas
Hold
$252.33
+21.8%
Low: $220.00
High: $275.00
P/E Futuro
20.0
EPS Futuro
$10.31
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
260 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$17.35
$16.88 – $17.96
|
370 B | 1 |
| FY2029 |
$14.88
$14.48 – $15.40
|
330 B | 1 |
| FY2028 |
$13.03
$11.84 – $14.17
|
300 B | 5 |
Puntos Clave
Revenue grew 8.19% annually over 5 years — modest growth
Earnings grew 83.22% over the past year
Generating 1.85B in free cash flow
P/E of 31.24 — premium valuation
PEG of 0.30 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 10.06%
Crecimiento
Revenue Growth (5Y)
8.19%
Revenue (1Y)-1.87%
Earnings (1Y)83.22%
FCF Growth (3Y)-11.52%
Calidad
Return on Equity
N/A
ROIC25.99%
Net Margin0.70%
Op. Margin1.02%
Seguridad
Debt / Equity
N/A
Current Ratio0.94
Interest Coverage10.58
Valoración
P/E Ratio
31.24
P/B RatioN/A
EV/EBITDA23.84
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.87% | Revenue Growth (3Y) | 4.20% |
| Earnings Growth (1Y) | 83.22% | Earnings Growth (3Y) | 117.49% |
| Revenue Growth (5Y) | 8.19% | Earnings Growth (5Y) | 26.43% |
| Profitability | |||
| Revenue (TTM) | 222.58B | Net Income (TTM) | 1.56B |
| ROE | N/A | ROA | 2.94% |
| Gross Margin | 3.67% | Operating Margin | 1.02% |
| Net Margin | 0.70% | Free Cash Flow (TTM) | 1.85B |
| ROIC | 25.99% | FCF Growth (3Y) | -11.52% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.94 |
| Interest Coverage | 10.58 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 31.24 | P/B Ratio | N/A |
| P/S Ratio | 0.22 | PEG Ratio | 0.30 |
| EV/EBITDA | 23.84 | Dividend Yield | 0.01% |
| Market Cap | 48.76B | Enterprise Value | 54.24B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 222.58B | 226.83B | 204.98B | 181.33B | 162.47B |
| Net Income | 1.56B | 852.00M | 330.00M | -938.00M | 611.00M |
| EPS (Diluted) | 6.45 | 3.45 | 1.26 | -3.34 | 2.08 |
| Gross Profit | 8.17B | 7.41B | 6.89B | 6.48B | 6.78B |
| Operating Income | 2.28B | 1.24B | 752.00M | -607.00M | 472.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 53.12B | 45.12B | 43.35B | 43.88B | 44.45B |
| Total Liabilities | 55.76B | 48.33B | 46.31B | 44.58B | 42.66B |
| Shareholders' Equity | -2.78B | -3.21B | -2.96B | -709.00M | 1.79B |
| Total Debt | 9.35B | 5.61B | 5.18B | 5.81B | 6.72B |
| Cash & Equivalents | 3.87B | 5.13B | 4.08B | 4.72B | 3.41B |
| Current Assets | 36.37B | 34.88B | 33.74B | 32.94B | 31.05B |
| Current Liabilities | 38.90B | 35.64B | 33.74B | 30.55B | 27.62B |